Pfizer/BioNTech Announce New SARS-CoV-2 Injection
This was originally sent in January 25, 2022. Time flies, and people dies, eh?! :O(
[Note from Hedley: I’m busy putting the finishing touches to my next book for Wiley, of Hoboken, NJ. The title will be ‘Transforming the Pharmaceutical Supply Chain.’ To make up some time, I have been and will continue to recycle posts from the paid archives. This one is a belter!]
Pfizer/BioNTech Announcement
An article in Fierce Biotech, January 25 2022, titled Pfizer, BioNTech launch trial for potential omicron-busting vaccine, announced that Pfizer and BioNTech are launching a new clinical trial to test a potential omicron-busting COVID-19 vaccine.
The press release, Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age is shown here.
Important Safety Information
Included in the press release is some very helpful information:
Individuals should NOT get the vaccine if they:
had a severe allergic reaction after a previous dose of this vaccine
had a severe allergic reaction to any ingredient of this vaccine
Individuals should tell the vaccination provider about all of their medical conditions, including if they:
have any allergies
have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart) (Note from Hedley: they knew about it even then).
have a fever
have a bleeding disorder or are on a blood thinner
are immunocompromised or are on a medicine that affects the immune system
are pregnant, plan to become pregnant, or are breastfeeding
have received another COVID-19 vaccine
have ever fainted in association with an injection
The entire document is well worth a read.
What jumped out at me instantly is the warning that you should not get the jab if you have “had a severe allergic reaction to any ingredient of this vaccine”
How would anyone know what all the ingredients are?
It’s the Supply Chain that worries me, though
Not being medically qualified, I must leave it to others to comment on the trial itself.
The thing I am qualified to speak about though, is supply chain matters.
This will be a completely new product, with an active ingredient (drug substance) that will have to be made from scratch. Then it has to be shipped to another company to do the fill/finish operation, where the drug substance is filled into vials, bungs inserted and seals applied.
Then to another company to be frozen down to -70°C in trays of 195 units per tray, and packed into a bulk container filled with dry ice to keep it at that temperature.
Extensive safety testing must be carried out on the Product once it is completed.
Is there a magic wand we don’t know about?
The only explanation I can think of to explain this monumental ambition, is that the companies have a magic wand we don’t know about, as the press release goes on to say:
To big fn pharma. FYATH!
Full warp speed insanity...thank you Donald.